KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) has attracted significant investment activity from Venrock Healthcare Capital ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Currrax Pharmaceuticals over-performed its 2024 revenue goal and has exceeded 50% year-over-year revenue growth for its ...

The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

West Pharmaceutical Services forecast full-year profit and revenue below Wall Street estimates on Thursday due to a strong ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.

“Companies are realizing that investing stateside can provide more control and resilience to the drug supply chain,” says ...

Stock analysts at StockNews.com assumed coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Get Free Report) in a research report issued on Saturday. The firm set a “hold” rating on the ...

Choreo LLC trimmed its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange ...